MedPath

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Completed
Conditions
Actinic Keratosis
Interventions
Drug: Lesion count
Registration Number
NCT00989313
Lead Sponsor
Peplin
Brief Summary

This study is designed to follow up patients, who have participated in the PEP005-028 study and observed complete clearance of their Actinic Keratosis (AK) lesions, over a 12 month period to assess both recurrence of AK lesions and long term safety in the selected treatment area.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1Lesion count-
Primary Outcome Measures
NameTimeMethod
Summarize treatment area recurrence of AK lesions, in the selected treatment area during a 12 month follow-up period for patients with complete clearance, who have completed Day 57 in Study PEP005-028.12 months
Secondary Outcome Measures
NameTimeMethod
Summarize long-term safety data, in the selected treatment area over a 12 month follow-up period for patients with complete clearance, who have completed Day 57 in Study PEP005-028.12 months

Trial Locations

Locations (17)

Burke Pharmaceutical Research

🇺🇸

Hot Springs, Arizona, United States

Skin Surgery Medical Group Inc.

🇺🇸

San Diego, California, United States

Atlanta Dermatology, Vein & Research Center, LLC

🇺🇸

Alpharetta, Georgia, United States

Altman Dermatology Associates

🇺🇸

Arlington Heights, Illinois, United States

Glazer Dermatology

🇺🇸

Buffalo Grove, Illinois, United States

Deaconess Clinic Downtown

🇺🇸

Evansville, Indiana, United States

Dawes Fretzin Clinical Research Group, LLC

🇺🇸

Indianapolis, Indiana, United States

Skin Specialists, PC

🇺🇸

Omaha, Nebraska, United States

Karl G. Heine Dermatology

🇺🇸

Henderson, Nevada, United States

Group Health Associates

🇺🇸

Cincinnati, Ohio, United States

Scroll for more (7 remaining)
Burke Pharmaceutical Research
🇺🇸Hot Springs, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.